Oriva Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 12-12-2024
- Revenue 13.85%
(FY 2022)
- Profit 29.96%
(FY 2022)
- Ebitda 59.86%
(FY 2022)
- Net Worth 13.89%
(FY 2022)
- Total Assets 5.49%
(FY 2022)
About Oriva Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.50 M.
Anupma and Pavan Kumar serve as directors at the Company.
- CIN/LLPIN
U85100DL2011PTC227980
- Company No.
227980
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Oriva Life Sciences Private Limited offer?
Oriva Life Sciences Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Cardiovascular Drugs & Medication, Kidney Drugs.
Who are the key members and board of directors at Oriva Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupma  | Director | 28-Nov-2011 | Current |
| Pavan Kumar | Director | 28-Nov-2011 | Current |
Financial Performance of Oriva Life Sciences.
Oriva Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.85% increase. The company also saw a substantial improvement in profitability, with a 29.96% increase in profit. The company's net worth Soared by an impressive increase of 13.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oriva Life Sciences?
Unlock access to Oriva Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Mar 2023 | ₹1.50 M | Open |
How Many Employees Work at Oriva Life Sciences?
Oriva Life Sciences has a workforce of 14 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oriva Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oriva Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
